A carregar...
Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds
The human epidermal growth factor receptor 3 (HER3) has in recent years been recognized as a key node in the complex signaling network of many different cancers. It is implicated in de novo and acquired resistance against therapies targeting other growth factor receptors, e.g., EGFR, HER2, and it is...
Na minha lista:
| Publicado no: | MAbs |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5058629/ https://ncbi.nlm.nih.gov/pubmed/27532938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1212147 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|